Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience

Abdelrahim, M; Victor, D; Esmail, A; Kodali, S; Graviss, EA; Nguyen, DT; Moore, LW; Saharia, A; McMillan, R; Fong, JN; Uosef, A; Elshawwaf, M; Heyne, K; Ghobrial, RM

Abdelrahim, M (通讯作者)，Houston Methodist Canc Ctr, Sect GI Oncol, Dept Med Oncol, Houston, TX 77030 USA.;Abdelrahim, M (通讯作者)，Houston Methodist Res Inst, Cockrell Ctr Adv Therapeut Phase 1 Program, Houston, TX 77030 USA.;Abdelrahim, M (通讯作者)，Houston Methodist Res Inst, Canc Clin Trials, Houston, TX 77030 USA.;Abdelrahim, M (通讯作者)，Weill Cornell Med Coll, New York, NY 10021 USA.

CANCERS, 2022; 14 (3):

Abstract

Simple Summary Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third most common cause of cancer-related mortality worldwid......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索